MedTrace Logo

Helicobacter Pylori Antibiotic Susceptibility Testing of Korea

NCT02961296 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-11-10

No results posted yet for this study

Summary

The purpose of this study is to make nationwide registry for antimicrobial resistance of Helicobacter pylori using single method with agar dilution in Korea.

Conditions

Interventions

OTHER

No intervention

No intervention will be needed.

Sponsors & Collaborators

  • National Evidence-Based Healthcare Collaborating Agency

    collaborator OTHER_GOV

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Hwoon-Yong Jung, Professor · Asan Medical Center

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961296 on ClinicalTrials.gov